Transapical transcatheter aortic valve implantation using the JenaValve system: acute and 30-day results of the multicentre CE-mark study
Population
73 patients with severe aortic stenosis at high risk for conventional heart surgery, mean age 83.1 ± 3.9…
Design
Cohort
Follow-up
30 days (primary endpoint), with evaluations up to 12 months
Authors
Discussion
Loading...
Member takes
Implication
Supports JenaValve TAVI consideration in high-risk elderly; leaves open randomized confirmation of durability and broader outcomes.
Structured PICO
P
Population
73 patients with severe aortic stenosis (AS) at high risk for conventional heart surgery, mean age 83.1 ± 3.9, EuroSCORE 28.4 ± 6.5%. Enrolled at seven German sites.
I
Intervention
Transapical transcatheter aortic valve implantation using the JenaValve system (a porcine root valve mounted on a nitinol stent with feeler-guided positioning and clip fixation)
O
Outcome
All-cause mortality at 30 dayshard clinical
Transapical TAVI using the second-generation JenaValve system is safe and effective, demonstrating high procedural success and low 30-day mortality in elderly patients at high surgical risk.
Cite This Study
Treede et al. (2012) studied this question.